Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02534675 · ClinicalTrials.gov registry record
Study of Molecular Profile-Related Evidence to Determine Individualized Therapy for Advanced or Poor Prognosis Cancers
A clinical trial of Cancer, sponsored by University of California, San Diego.
- Completed
- Registry status
- 506
- Enrollment target
- 2
- Study locations
NCT02534675 is a study of Cancer that has completed, run by University of California, San Diego. The registered enrollment target is 506 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT02534675, a study of Cancer, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 506 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to learn more about personalized cancer therapy including response to treatment and side effects. Information from the patient's medical record regarding the tests and treatments they have received, or will receive, for their cancer will be collected. Genomic testing on tissue from the primary tumor or metastases will be used to match therapy recommendations. Patients in which there is no appropriate matched therapy will receive systemic chemotherapy according to their treating physician's discretion. This information will be used to describe whether or not patients respond better when their physicians choose to treat them according to the genetic makeup of their tumor.
Conditions Studied
Study Locations (2)
California
- UCSD Moores Cancer Center - La Jolla
South Dakota
- Avera Cancer Institute - Sioux Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 506 participants |
| Start Date | 2015-02 |
| Est. Completion | 2022-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02534675
The ClinicalTrials.gov registry entry for NCT02534675 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 506 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (86% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT02534675 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, South Dakota.
Frequently Asked Questions
What is clinical trial NCT02534675 about?
NCT02534675 is a clinical study titled "Study of Molecular Profile-Related Evidence to Determine Individualized Therapy for Advanced or Poor Prognosis Cancers". The purpose of this study is to learn more about personalized cancer therapy including response to treatment and side effects. Information from the patient's medical record regarding the tests and treatments they have received, or will receive, for their cancer will be collected. Genomic testing on ...
What is the current status of trial NCT02534675?
This trial is currently completed. The enrollment target is 506 participants. The study started on 2015-02. Estimated completion is 2022-12-01.
What conditions does trial NCT02534675 study?
This clinical trial studies the following conditions: Cancer.
Who is sponsoring clinical trial NCT02534675?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02534675 being conducted?
This trial has 2 study locations across California, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.